Foghorn Therapeutics is a startup based in the United States, 1 tracked investor.
Foghorn Therapeutics is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Foghorn Therapeutics develops therapies targeting the epigenetic machinery to treat cancer and other serious diseases by modulating chromatin regulatory proteins.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.